Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: PHC018
MIFTS: 39

Phace Association

Categories: Cardiovascular diseases, Fetal diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Phace Association

About this section

MalaCards integrated aliases for Phace Association:

Name: Phace Association 56 74 52 71
Phace Syndrome 52 58 6
Pascual-Castroviejo Syndrome Type 2 52 58
Phaces Association 56 52
Posterior Fossa Brain Malformations, Hemangiomas of the Face, Arterial Anomalies, Cardiac Anomalies, and Eye Abnormalities 52
Pascual-Castroviejo Type Ii Syndrome 52
Aortic Aneurysm, Giant Congenital 56
Phaces Syndrome 58
P-Ciis 52

Characteristics:

Orphanet epidemiological data:

58
phace syndrome
Inheritance: X-linked dominant; Prevalence: <1/1000000 (Worldwide); Age of onset: Antenatal,Infancy,Neonatal;

OMIM:

56
Inheritance:
isolated cases

Miscellaneous:
phace is an acronym for posterior fossa brain malformation, large facial hemangiomas, arterial anomalies, cardiac anomalies and aortic coarctation, and eye abnormalities
87% patients are female


HPO:

31
phace association:
Inheritance sporadic x-linked dominant inheritance


Classifications:

MalaCards categories:
Global: Rare diseases Fetal diseases
Anatomical: Neuronal diseases Cardiovascular diseases
See all MalaCards categories (disease lists)
ICD10: 33
Orphanet: 58  
Rare neurological diseases
Rare circulatory system diseases
Rare cardiac malformations
Developmental anomalies during embryogenesis


Sources

Summaries for Phace Association

About this section
NIH Rare Diseases : 52 PHACE syndrome is the association of a large hemangioma , usually on the face or neck, in combination with one or more other birth defects . People with PHACE syndrome may have P osterior fossa brain malformations, H emangioma, A rterial lesions (blood vessel abnormalities in the head or neck), C ardiac (heart) abnormalities/aortic coarctation , and E ye abnormalities. Symptoms and symptom severity may vary from person to person. The cause of the condition is currently unknown. It affects girls much more often than boys. Treatment is based on the signs and symptoms present in the person.

MalaCards based summary : Phace Association, also known as phace syndrome, is related to cerebral cortical dysplasia and sternal cleft, and has symptoms including seizures An important gene associated with Phace Association is BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase). The drugs Propranolol and Nadolol have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and heart, and related phenotypes are abnormal cerebral artery morphology and glaucoma

OMIM : 56 PHACE is an acronym for a neurocutaneous syndrome encompassing the following features: posterior fossa brain malformations, hemangiomas of the face (large or complex), arterial anomalies, cardiac anomalies, and eye abnormalities. The association is referred to as PHACES when ventral developmental defects, such as sternal clefting or supraumbilical raphe, are present (summary by Bracken et al., 2011). (606519)

Wikipedia : 74 PHACE syndrome is a cutaneous condition characterized by multiple congenital abnormalities. The mnemonic... more...

Sources

Related Diseases for Phace Association

About this section

Diseases related to Phace Association via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 109)
# Related Disease Score Top Affiliating Genes
1 cerebral cortical dysplasia 10.4
2 sternal cleft 10.4
3 hemangioma 10.3
4 congenital hypothyroidism 10.3
5 microphthalmia 10.3
6 posterior fossa malformation 10.3
7 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.2
8 subglottic angioma 10.2
9 transient cerebral ischemia 10.2
10 dandy-walker syndrome 10.1
11 ptosis 10.1
12 horner's syndrome 10.1
13 heart septal defect 10.1
14 capillary hemangioma 10.1
15 pituitary gland disease 10.1
16 glial tumor 10.1
17 gastroenteritis 10.1
18 cerebral cavernous malformations 10.0
19 retinoblastoma 10.0
20 strabismus 10.0
21 tetralogy of fallot 10.0
22 arterial tortuosity syndrome 10.0
23 persistent hyperplastic primary vitreous, autosomal recessive 10.0
24 moyamoya disease 1 10.0
25 hypogonadotropic hypogonadism 10.0
26 sensorineural hearing loss 10.0
27 pre-eclampsia 10.0
28 hydrocephalus 10.0
29 placenta praevia 10.0
30 arteriovenous malformation 10.0
31 eclampsia 10.0
32 ventricular septal defect 10.0
33 hypogonadism 10.0
34 familial retinoblastoma 10.0
35 cataract 10.0
36 mechanical strabismus 10.0
37 exophthalmos 10.0
38 aortic arch interruption 10.0
39 glioma 10.0
40 dysphagia 10.0
41 ectopia cordis 10.0
42 congenital oculomotor nerve palsy 10.0
43 moyamoya angiopathy 10.0
44 hypopituitarism 10.0
45 anisocoria 9.9
46 coloboma of macula 9.9
47 hyperhidrosis, gustatory 9.9
48 lacrimal duct defect 9.9
49 marfan syndrome 9.9
50 pectus excavatum 9.9

Graphical network of the top 20 diseases related to Phace Association:



Diseases related to Phace Association
Sources

Symptoms & Phenotypes for Phace Association

About this section

Human phenotypes related to Phace Association:

58 31 (show top 50) (show all 52)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 abnormal cerebral artery morphology 58 31 hallmark (90%) Very frequent (99-80%) HP:0009145
2 glaucoma 58 31 frequent (33%) Frequent (79-30%) HP:0000501
3 microphthalmia 58 31 frequent (33%) Frequent (79-30%) HP:0000568
4 abnormal cardiac septum morphology 58 31 frequent (33%) Frequent (79-30%) HP:0001671
5 dandy-walker malformation 58 31 frequent (33%) Frequent (79-30%) HP:0001305
6 optic nerve hypoplasia 58 31 frequent (33%) Frequent (79-30%) HP:0000609
7 cerebral arteriovenous malformation 58 31 frequent (33%) Frequent (79-30%) HP:0002408
8 cataract 58 31 occasional (7.5%) Occasional (29-5%) HP:0000518
9 global developmental delay 58 31 occasional (7.5%) Occasional (29-5%) HP:0001263
10 muscular hypotonia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001252
11 microcephaly 58 31 occasional (7.5%) Occasional (29-5%) HP:0000252
12 hypothyroidism 58 31 occasional (7.5%) Occasional (29-5%) HP:0000821
13 hemiplegia/hemiparesis 58 31 occasional (7.5%) Occasional (29-5%) HP:0004374
14 strabismus 58 31 occasional (7.5%) Occasional (29-5%) HP:0000486
15 ptosis 58 31 occasional (7.5%) Occasional (29-5%) HP:0000508
16 coarctation of aorta 58 31 occasional (7.5%) Occasional (29-5%) HP:0001680
17 iris coloboma 58 31 occasional (7.5%) Occasional (29-5%) HP:0000612
18 tetralogy of fallot 58 31 occasional (7.5%) Occasional (29-5%) HP:0001636
19 amblyopia 58 31 occasional (7.5%) Occasional (29-5%) HP:0000646
20 heterochromia iridis 58 31 occasional (7.5%) Occasional (29-5%) HP:0001100
21 sclerocornea 58 31 occasional (7.5%) Occasional (29-5%) HP:0000647
22 agenesis of corpus callosum 58 31 occasional (7.5%) Occasional (29-5%) HP:0001274
23 capillary hemangioma 58 31 occasional (7.5%) Occasional (29-5%) HP:0005306
24 visceral angiomatosis 58 31 occasional (7.5%) Occasional (29-5%) HP:0100761
25 cerebellar hypoplasia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001321
26 abnormality of the sternum 58 31 occasional (7.5%) Occasional (29-5%) HP:0000766
27 aortic root aneurysm 58 31 occasional (7.5%) Occasional (29-5%) HP:0002616
28 ectopic thyroid 58 31 occasional (7.5%) Occasional (29-5%) HP:0100028
29 retinal vascular malformation 58 31 occasional (7.5%) Occasional (29-5%) HP:0007797
30 lens coloboma 58 31 occasional (7.5%) Occasional (29-5%) HP:0100719
31 abnormality of the orbital region 31 occasional (7.5%) HP:0000315
32 seizure 31 occasional (7.5%) HP:0001250
33 abnormal carotid artery morphology 31 occasional (7.5%) HP:0005344
34 seizures 58 Occasional (29-5%)
35 optic atrophy 31 HP:0000648
36 patent ductus arteriosus 31 HP:0001643
37 ventricular septal defect 31 HP:0001629
38 abnormality of the carotid arteries 58 Occasional (29-5%)
39 arterial stenosis 31 HP:0100545
40 migraine 31 HP:0002076
41 abnormal heart morphology 58 Frequent (79-30%)
42 aortic aneurysm 31 HP:0004942
43 congenital hypothyroidism 31 HP:0000851
44 horner syndrome 31 HP:0002277
45 developmental cataract 31 HP:0000519
46 abnormality of the ocular region 58 Occasional (29-5%)
47 cavernous hemangioma of the face 31 HP:0007486
48 anomalous branches of internal carotid artery 31 HP:0005314
49 plaque-like facial hemangioma 31 HP:0007434
50 increased retinal vascularity 31 HP:0007986

Symptoms via clinical synopsis from OMIM:

56
Neurologic Central Nervous System:
seizures
dandy-walker malformation
cerebellar hypoplasia
developmental delay
migraine headaches (ipsilateral to facial hemangioma)
more
Cardiovascular Vascular:
patent ductus arteriosus
arterial stenosis
anomalous branches of internal carotid artery
coarctation of the aorta
steal syndrome
more
Head And Neck Face:
facial hemangioma

Respiratory Larynx:
subglottic hemangioma

Abdomen External Features:
supraumbilical abdominal raphe

Head And Neck Eyes:
optic atrophy
optic nerve hypoplasia
increased retinal vascularity
congenital cataract
horner's syndrome
more
Cardiovascular Heart:
ventricular septal defect

Endocrine Features:
congenital hypothyroidism
lingual thyroid

Chest Ribs Sternum Clavicles And Scapulae:
sternal clefting
sternal pits

Skin Nails Hair Skin:
hemangioma, facial, plaque-like

Clinical features from OMIM:

606519

UMLS symptoms related to Phace Association:


seizures
Sources

Drugs & Therapeutics for Phace Association

About this section

Drugs for Phace Association (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 10)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propranolol Approved, Investigational Phase 2 525-66-6 4946
2
Nadolol Approved Phase 2 42200-33-9 39147
3 Adrenergic beta-Antagonists Phase 2
4 Antihypertensive Agents Phase 2
5 Adrenergic Agents Phase 2
6 Adrenergic Antagonists Phase 2
7 Sympatholytics Phase 2
8 Anti-Arrhythmia Agents Phase 2
9 Neurotransmitter Agents Phase 2
10 Dermatologic Agents

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Nadolol for Proliferating Infantile Hemangiomas: A Prospective Open Label Study With a Historical Control Completed NCT01010308 Phase 2 Nadolol
2 Longitudinal Study of Neurologic, Cognitive, and Radiologic Outcomes in PHACE Syndrome Completed NCT01018082
3 Hemangioma Associated With High Rates of Morbidity:A Prospective Study Completed NCT00394888
4 Genetic Analysis of PHACE Syndrome.(PHACE Syndrome is Defined as a Hemangioma Plus One or More of the Following: Brain, Heart, Eye, Sternal or Cerebral Artery Anomalies). Recruiting NCT01016756

Search NIH Clinical Center for Phace Association

Sources

Genetic Tests for Phace Association

About this section
Sources

Anatomical Context for Phace Association

About this section

MalaCards organs/tissues related to Phace Association:

40
Brain, Eye, Heart, Thyroid, Skin, Kidney, Pituitary
Sources

Publications for Phace Association

About this section

Articles related to Phace Association:

(show top 50) (show all 204)
# Title Authors PMID Year
1
PHACE syndrome: MRI of intracerebral vascular anomalies and clinical findings in a series of 12 patients. 61 56
21674285 2011
2
Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. 56 61
20705698 2010
3
Consensus Statement on Diagnostic Criteria for PHACE Syndrome. 56 61
19858157 2009
4
A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. 61 56
16575892 2006
5
Infantile orofacial hemangioma with ipsilateral peripapillary excavation in girls: a variant of the PHACE syndrome. 56 61
15006868 2004
6
Report of a child with aortic aneurysm, orofacial clefting, hemangioma, upper sternal defect, and marfanoid features: possible PHACE syndrome. 61 56
12116239 2002
7
The many faces of PHACE syndrome. 56 61
11445804 2001
8
PHACE: a neurocutaneous syndrome with important ophthalmologic implications: case report and literature review. 61 56
10485544 1999
9
PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. 61 56
8607636 1996
10
Giant congenital aortic aneurysm with cleft sternum, supraumbilical raphé, and hemangiomatosis: report and review. 56
10678663 2000
11
Sternal cleft associated with vascular anomalies and micrognathia. 56
8328853 1993
12
Aneurysm of the ascending aorta associated with sternal cleft, cutaneous hemangioma, and occlusion of the right innominate artery in a neonate. 56
3541557 1987
13
Vascular and nonvascular intracranial malformation associated with external capillary hemangiomas. 56
740218 1978
14
PHACE syndrome: importance of distinguishing infantile haemangioma from capillary malformation. 61
32522758 2020
15
PHACE Syndrome: A Rare Case. 61
31976140 2020
16
Frey syndrome-like developmental dysautonomia in a child with PHACE syndrome. 61
32101632 2020
17
Hamartomas and midline anomalies in association with infantile hemangiomas, PHACE, and LUMBAR syndromes. 61
31631401 2020
18
Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome. 61
31825455 2019
19
Intrathoracic hybrid lesion: an incidental finding in a patient with PHACE syndrome. 61
31780601 2019
20
A case of PHACE syndrome with growth hormone deficiency and abnormal thyroid functions. 61
31473685 2019
21
Dieulafoy lesions and PHACE syndrome. 61
31359449 2019
22
Infantile hemangioma of the upper lip and enamel hypoplasia: Two case reports. 61
31468572 2019
23
Facial segmental haemangioma with PHACE Syndrome successfully treated with oral propranolol. 61
31649228 2019
24
Natural history of PHACE syndrome: A survey of adults with PHACE. 61
31222913 2019
25
Endocrine manifestations of PHACE syndrome. 61
31323007 2019
26
Dental root abnormalities in four children with PHACE syndrome. 61
30933385 2019
27
Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants. 61
31037424 2019
28
Persistent stapedial artery in PHACE syndrome. 61
30876851 2019
29
PHACE syndrome with unnoticeable skin lesion and rare anomaly of coronary artery. 61
31090165 2019
30
Surgery on a dilated aorta associated with a connective tissue disease or inflammatory vasculitis in children and adolescents. 61
31111802 2019
31
Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization. 61
30717056 2019
32
Late growth of infantile hemangiomas in children >3 years of age: A retrospective study. 61
30293898 2019
33
Two Cases of Oculofaciocardiodental (OFCD) Syndrome due to X-Linked BCOR Mutations Presenting with Infantile Hemangiomas: Phenotypic Overlap with PHACE Syndrome. 61
31956451 2019
34
Ocular Complications in PHACE Syndrome: A True Association or a Coincidence? 61
30270159 2019
35
Transient ischemic attack in elderly patient with PHACE syndrome. 61
31637089 2019
36
PHACE syndrome and hearing loss. 61
31644633 2019
37
Unsolved recognizable patterns of human malformation: Challenges and opportunities. 61
30580485 2018
38
PHACE syndrome: Infantile hemangiomas associated with multiple congenital anomalies: Clues to the cause. 61
30580483 2018
39
Distal aortic arch aneurysm in an adult case of PHACE syndrome. 61
29672688 2018
40
Infantile hemangioma with minimal or arrested growth as the skin manifestation of PHACE syndrome. 61
29984853 2018
41
Hearing loss in PHACE syndrome: clinical and radiologic findings. 61
29748705 2018
42
Regarding: "Localized Marked Elongation of the Distal Internal Carotid Artery with or without PHACE Syndrome: Segmental Dolichoectasia of the Distal Internal Carotid Artery". 61
29853523 2018
43
Infantile hemangiomas: what have we learned from propranolol? 61
29846253 2018
44
PHACE syndrome: clinical manifestations, diagnostic criteria, and management. 61
29924216 2018
45
Localized Marked Elongation of the Distal Internal Carotid Artery with or without PHACE Syndrome: Segmental Dolichoectasia of the Distal Internal Carotid Artery. 61
29545249 2018
46
Open resection and laryngotracheal reconstruction in a case of subglottic hemangioma in PHACE syndrome. 61
29605352 2018
47
PHACE Syndrome-before and after Propranolol Therapy. 61
29221694 2018
48
Holmes heart and tetralogy of Fallot in association with PHACE. 61
29243304 2018
49
Atypical Presentation of PHACE Syndrome: Hidden Facial Hemangioma. 61
30336486 2018
50
Structural malformations of the brain, eye, and pituitary gland in PHACE syndrome. 61
29171184 2018
Sources

Variations for Phace Association

About this section

ClinVar genetic disease variations for Phace Association:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 BRAF NM_001374258.1(BRAF):c.1720G>C (p.Gly574Arg)SNV Pathogenic/Likely pathogenic 13980 rs180177041 7:140476806-140476806 7:140777006-140777006

Copy number variations for Phace Association from CNVD:

7
# CNVD ID Chromosome Start End Type Gene Symbol CNVD Disease
1 220052 7 133600015 133700204 Deletion SLC35B4 PHACE syndrome
Sources

Expression for Phace Association

About this section
Search GEO for disease gene expression data for Phace Association.
Sources

Pathways for Phace Association

About this section
Sources

GO Terms for Phace Association

About this section
Sources

Sources for Phace Association

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....